People in Britain Say Find Aliens, Cure Cancer

Publication
Article
Oncology & Biotech NewsDecember 2010
Volume 4
Issue 12

A recent poll conducted by Britain's Royal Society found that what Britons want most is a vaccine that will prevent cancer.

A recent poll conducted by Britain’s Royal Society found that what Britons want most is a vaccine that will prevent cancer, with nearly 80% of respondents selecting it as their top priority for science. Of the 2000 people surveyed, 60% picked HIV/AIDS prevention as their next choice. Although 44% expressed a belief in aliens and more than one-third think scientists should be trying to find and contact them, less than 10% identified space exploration as a top priority for science.

Related Videos
Thomas F. Gajewski, MD, PhD
Michelle Krogsgaard, PhD
In this fifth episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss next steps for research, including vaccination strategies, personalized cellular therapies, and more.
In this fourth episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts discuss research efforts being made with organoids to address existing questions with immunotherapy and the exploration of multimodality approaches to improve outcomes.
In this third episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss the potential benefits of utilizing immunotherapy approaches earlier on in the disease course.
In this second episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, explain the challenges faced with preventing or detecting these cancers early and the understanding that is needed to develop effective early detection methods and move the needle forward.
In this first episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss the potential for early detection multiomic assays and the work that still needs to be done to encourage their widespread use.
Paul Nathan, MBBS, PhD, FRCP
Joachim G. J. V. Aerts, MD, PhD
Nathaniel Myall, MD